Skip to main content

Advertisement

Relation between carotid vulnerable plaques and peripheral leukocyte: a case-control study of comparison utilizing multi-parametric contrast-enhanced ultrasound

Article metrics

  • 186 Accesses

Abstract

Background

This study evaluates carotid vulnerable plaques using contrast-enhanced ultrasound (CEUS) and explores the relationship between vulnerable plaques and leukocytes.

Methods

Sixty-two symptomatic and 54 asymptomatic patients underwent CEUS. The images were analyzed using time-intensity and fitting curves, and peak (PTIC), mean (MTIC), peak (PFC), sharpness (SFC), and area under the curve (AUCFC) were obtained. The relations between CEUS parameters and leukocytes were analyzed.

Results

In the symptomatic group, total leukocytes and neutrophils were higher, while lymphocyte was decreased; PTIC, MTIC, PFC, SFC, and AUCFC were significantly higher; MTIC and AUCFC were negatively correlated with lymphocytes, and MTIC was positively correlated with neutrophils. Classification and regression tree analysis showed that MTIC at a cutoff of 20.8 and AUCFC at a cutoff of 8.8 resulted in a predictive of acute cerebral infarction, accuracy of 84.3%, sensitivity of 87.1%, and specificity of 81.5%.

Conclusions

The variation in the perivascular leucocyte is significantly related to intraplaque inflammatory activities, CEUS is a feasible monitor of intraplaque neovascularization, so CEUS combined with perivascular leucocyte could be helpful as a warning for vulnerable plaques.

Background

Acute cerebral infarction (ACI) is the main cause of adult disability, cognitive impairment, and mortality worldwide [1]. The large artery atherosclerosis cerebral infarction subtype is closely correlated with the presence of vulnerable plaques [2]. Intraplaque neovascularization (IPN) is also a surrogate marker of vulnerable plaques. Previous studies have confirmed a pronounced association between IPN, plaque vulnerability, and cerebrovascular events [3]. Plaque rupture and clinical events appear to be initiated and triggered by vascular leakage, inflammatory cell recruitment, and intraplaque hemorrhage, and all of these are consistent with plaque inflammation processes. Inflammatory activity in the plaque is closely associated with the inflammatory state of the outside system. Notably, atherosclerotic lesions, which contain monocyte-derived macrophages, T lymphocytes, and leukocytosis, are involved in plaque thickness in the carotid artery [4]. Variations in the leucocyte count in the peripheral circulating blood can reflect the inflammatory state of the system to some extent [5].

Contrast-enhanced ultrasound (CEUS) provides direct visualization of the IPN in carotid plaques [6]. Several studies have recently described a positive correlation between the histological density of neovessels and the presence of neovascularization in carotid plaques detected by CEUS [7].

Leukocyte count is a common blood test in clinical practice. A high leukocyte count may reflect a chronic inflammatory state and contribute directly to atherosclerosis through specific mechanisms [8]. The peripheral leukocyte count is a non-traditional risk factor of ACI and has predictive value for ACI prognosis [9]. A relationship between plaque angiogenesis and increased plaque instability and ACI has been established; however, the implications of the peripheral leukocyte count and IPN in carotid plaques assessed by CEUS remain unknown. Therefore, this study investigated the relationship between the peripheral leukocyte count and IPN.

Methods

Patient selection

We searched the patient database at the Department of Neurology, Shanghai General Hospital Health System, and an institution with Primary Stroke Center Certification from the China Stroke Center Alliance, to identify all patients who underwent CEUS of the carotid arteries between June 2016 and June 2017. The inclusion criteria were ≥ 50% extracranial carotid artery stenosis secondary to atherosclerosis disease based on a conventional carotid ultrasound, CTA, MRA, and/or catheter angiogram. Patients were then classified as symptomatic, defined as having ischemic neurological symptoms (stroke, transient ischemic attack, or amaurosis fugax) relevant to the index carotid lesion within 7 days of undergoing CEUS, or as asymptomatic. Exclusion criteria included (1) non-atherosclerotic intracranial vascular pathology (e.g., reversible cerebral vasoconstriction syndrome, Moyamoya disease, vasculitis), (2) the presence of potential sources of cardioembolism, (3) contradictions for the use of ultrasonic contrast agents, such as acute cardiac failure, unstable angina, and acute endocarditis, (4) known allergy to micro-bubble contrast agents, (5) a recent history of active bleeding, (6) patients with hematological diseases, malignant tumors, or severe liver, kidney, or pulmonary diseases, or (7) patients had underwent endarterectomy previously.

During the study period, 849 patients underwent the ultrasound, CTA, MRA, or catheter angiogram of the carotid arteries; 551 patients were excluded secondary to a lack of significant stenosis (≥50%). One hundred twenty-eight were excluded secondary to conflict causes of neurological symptoms, e.g., lacunar infarction or cardiac emboli. Thirty-five patients were excluded for previous carotid endarterectomy with restenosis and 19 for tandem lesions. Finally, 54 patients classified as asymptomatic had no history of symptoms, neither remote or at the time of examination, as determined with a detailed neurological examination by an experienced vascular surgeon. Sixty-two patients who were included in this study had acute large artery atherosclerotic stroke. To further analyze the impact of the medical history on the results, the patients were divided into two subgroups: Subgroup 1 (with a history of ACI, 28 patients) and Subgroup 2 (ACI for the first time, 34 patients) and were and analyzed using stratified analysis. To prove whether the IPN from CEUS and leukocyte count are related, we compared the data from the ACI patients with the different medical histories.

All subjects stopped daily medications 24 h before the examination and did not take their blood pressure medication on the day of examination. The general information and medical history of each patient were collected. Diabetes mellitus was diagnosed according to the WHO diagnostic criteria, which are random plasma glucose more than 11.1 mmol/L or fasting plasma glucose 7 mmol/L or higher [10]. The diagnostic standard for hypertension was based on the American Heart Association/American College of Cardiology guidelines. The morning fasting venous blood samples of all subjects were collected to analyze the total leukocyte, lymphocyte, and neutrophil counts. The systolic pressure and diastolic pressure of the brachial artery were measured three times in a resting state, which was taken as an average.

Clinical investigations were performed according to the Declaration of Helsinki. The study protocol was approved by the ethics committee of Shanghai General Hospital (2017KY009) and registered with the official website of China Clinical Trial Registration Center (ChiCTR1800016590). The inform consents were signed by all subjects.

Instruments and methods

Siemens S2000 (Siemens, Berlin, Germany) and Sequoia 512 ultrasound systems (Siemens Berlin, Germany) equipped with a 9-4-L MHz linear transducer and ultrasound contrast software (Cadence Contrast Pulse Sequencing) were used to acquire standard carotid ultrasound including color Doppler and CEUS.

Carotid ultrasound acquisition: All subjects had rested for 10 min in the supine position. According to previous research methods, both the left and right common carotid arteries, internal carotid arteries, external carotid arteries, and vertebral arteries were imaged by standard carotid ultrasound to record the number of atherosclerotic plaques and their distribution and to evaluate the degree of carotid artery stenosis [11, 12]. CEUS was performed on obvious plaques: (1) the far wall of carotid bifurcation or the initial part of the internal carotid artery; (2) those thicker than 2 mm, choosing the largest; (3) no calcification or the least calcified plaque; and (4) cerebral infraction ipsilateral to the side of the carotid plaque. Obvious plaque area (OPA), calcified area (CA), and calcified area/total plaque area (CA/TPA) were measured using velocity vector imaging (Siemens Medical Systems) [13]. TPA was defined as the sum of all plaque areas measured in any of the carotid artery segments within an individual [14, 15]. The contrast mode of the ultrasound system was fixed (presetting): mechanical index of 0.06–0.08, 90% gain, imaging depth of 2–3 cm and focusing on the back of the ideal plaques. SonoVue™ contrast agent (Bracco, Milan, Italy), 2.5 ml, was injected via the elbow vein in a 2.5 ml bolus followed by a saline flush of 5 ml NaCl 0.9% solution. For offline analysis, 90 s of cine clips were continuously digitally stored.

For quantitative analysis of the CEUS, quantitative analysis software (QontraXt, Esaote, Genoa, Italy) was adopted. The analytical method was chosen to acquire time-signal intensity curve quantitative parameters including the peak time-signal intensity (PTIC) and the mean time-signal intensity (MTIC), and the quantitative parameters for fitting the gamma curve of the TIC (FC) were maximum peak value (PFC), sharpness (SFC), and area under the curve (AUCFC).

Statistical analysis

Statistical analysis of the data was performed using SPSS version 13.0 software for Windows (SPSS Inc.). Continuous data were expressed as the mean ± standard deviation. Categorical variables are presented as counts (and percentages). Comparison of the continuous variables was performed by a two-sample Student’s t-test for normally distributed data. The chi-square test was used to compare the frequency of occurrence.

A multivariable regression model to predict ACI was developed considering 5 CEUS variables (PTIC, MTIC, PFC, SFC, and AUCFC) and 15 clinical variables (age, gender, BMI, SBP, DBP, history of hypertension, history of diabetes mellitus, FPG, TC, TC, LDL, HDL, leukocytes, lymphocytes, and neutrophils). These CEUS and clinical variables were entered into a backward logistic regression analysis and were chosen from the set of candidates by backward elimination. We also used a classification and regression tree analysis model, which created an inverted tree based on binary splitting choosing a variable value that best separated those with vulnerable plaques from those with stable plaques. Accuracy statistics were computed to assess the model performance including sensitivity, specificity, accuracy, and the area under the receiver operating characteristic curve (ROC).

Pearson’s correlation tests were performed to evaluate the correlation between the parameters, and scatter plots were examined to assess the association between PTIC, AUCFC, lymphocytes, and neutrophils.

The reproducibility of the parameters was assessed in 20 randomly selected patients whose PTIC and MTIC values were both measured independently by two physicians and twice by the same physician, respectively. The repeatability evaluation adopted a linear correlation analysis and Bland–Altman plots. Bland–Altman plots were used to assess inter-observer variability. Statistical significance was considered to exist at P < 0.05.

Results

Clinical characteristics

A total of 116 patients were included in the study: 62 symptomatic patients (48 males) with large artery atherosclerosis cerebral infarction and 54 asymptomatic patients (42 males) matched by age and sex. Patient clinical characteristics were summarized in Table 1. The mean values of the leukocyte and neutrophil counts in the symptomatic group were significantly higher than in the asymptomatic group; however, the mean value of the lymphocyte count was significantly lower than that in the asymptomatic group (P<0.05).

Table 1 Comparison of clinical characteristics between the two groups

Comparison of carotid plaque CEUS quantitative parameters

A total of 491 plaques were identified in the 116 patients. Two hundred forty-one plaques were detected in the common carotid artery, and 205 plaques were detected in the internal carotid artery. Though forty-five plaques were detected in the external carotid artery, they were not included in this study because the plaques in this site were not related to cerebrovascular events. Eighty-three patients had multiple plaques (mean, 3.6; range, 1–12), and sixty-six patients had plaques coexisting in the common carotid artery and internal carotid artery. The plaque characteristics of patients with and without history of the previous stroke were similar.

An obvious plaque was successfully selected to perform CEUS examination in each subject according to the following selection criteria: those located at the far wall of carotid bifurcation or the initial part of the internal carotid artery; those thicker than 2 mm, choosing the largest; no calcification or the least calcified plaque; and cerebral infraction ipsilateral to the side of the carotid plaque (Fig. 1). The mean values of PTIC, MTIC, PFC, SFC, and AUCFC in these cases were significantly higher than those in the controls (all P<0.05) (Table 2).

Fig. 1
figure1

CEUS and quantitative analysis images of carotid atherosclerotic plaques. A1–A3: acute cerebral infarction patients, B1–B3: asymptomatic patients. A1 and B1: the CEUS image shows no enhancement in the carotid plaque with asymptomatic patients, while significant enhancement (arrow) is observed in the carotid plaques with ACI patients. A2 and B2: 3D imaging of the perfusion parameters (parametric maps) is obtained from the carotid plaques using a scale of colors varying from red (maximum signal intensity) to blue (minimum signal intensity), passing through yellow and green. A3 and B3: quantitative analysis images of carotid atherosclerotic plaques; yellow arrow: IPN; green curve: time-intensity curve (TIC), blue curve: time-intensity fitting curve (FC). Numeric values of the peak, TP, sharpness, and AUC were automatically calculated based on the time-intensity curve and are shown at the top of the graphs

Table 2 Comparison of CEUS parameters of carotid plaques between the two groups

Comparison of data from symptomatic patients with different histories in two subgroups

To prove the correlation between IPN and peripheral leukocytes in Subgroups 1 and 2, a stratified analysis was used. There were no significant differences between Subgroups 1 and 2 in CEUS or leukocyte count. The neutrophil count showed a decreasing tendency in Subgroup 1, while PTIC and AUCFC showed an increasing trend in Subgroup 2. However, this difference was not statistically significant (Table 3).

Table 3 Comparison of data from the symptomatic patients with different histories in two subgroups

Repeatability test

The repeatability test showed that intergroup and intragroup comparisons had a high degree of consistency (Fig. 2).

Fig. 2
figure2

Repeatability was analyzed by Bland–Altman Plots (a-b) and linear correlation analysis (c-d) in the inter- and intragroups. The results showed a consistent trend in the difference value and the mean value of PTIC by repeated measurement. Inter- and intragroup comparisons had a high degree of consistency. PTIC: peak of the time-intensity curve

Correlations between carotid CEUS parameters and peripheral blood leukocyte count

MTIC and AUCFC modestly correlated with lymphocytes in the symptomatic patients (Fig. 3), while MTIC correlated closely with neutrophils only in the symptomatic group (Fig. 4).

Fig. 3
figure3

Correlations of AUCFC and MTIC with lymphocytes in ACI patients (a-b) and asymptomatic patients (c-d). AUCFC: area under the fitting curve; MTIC: mean of the time-intensity curve; AIS: acute ischemic stroke. Correlation coefficients and P-values are given in the graphs

Fig. 4
figure4

Correlations of AUCFC and MTIC with neutrophils in ACI patients (a-b) and asymptomatic patients (c-d). AUCFC: area under the fitting curve; MTIC: mean of the time-intensity curve; AIS: acute ischemic stroke. Correlation coefficients and P-values are given in the graphs

Diagnostic accuracy

Using a backward logistic regression model, only 2 variables (AUCFC and MTIC) were considered to be simultaneously significant and remained independent predictors of ACI when evaluated against other clinical and CEUS parameters.

ROC analysis showed the areas under the curves of AUCFC and MTIC to be 0.787 and 0.729, respectively (Fig. 5). The optimal AUCFC and MTIC cutoff values for detecting ACI were 9.57 and 20.8 dB with 83.0 and 69.8% sensitivity, 68.6 and 64.7% specificity, and 75.8 and 67.3% accuracy, respectively (Table 3).

Fig. 5
figure5

Receiver operating characteristic (ROC) curve for the CEUS parameters’ ability to predict vulnerable plaques in patients with ACI

Subsequently, a further classification tree model using a binary recursive partition method also confirmed significant contributions from the same 2 variables (AUCFC and MTIC), resulting in an improvement in overall diagnostic accuracy that was superior to that for each measure alone (Table 4).

Table 4 Cutoff, Sensitivity, Specificity, and Accuracy for AUCFC and MTIC

Using AUCFC at a cutoff of 8.8 and MTIC at a cutoff of 20.8, we were able to correctly identify 54 of 62 ACI patients (87.1%) and 44 of 54 non-ACI patients (81.5%) with an overall accuracy of 84.3%. The area under the ROC curve was 0.911.

Discussions

Cerebral infarction has some of the highest morbidity and mortality rates worldwide. Atherosclerotic plaque rupture is the leading cause of ACI [16]. Therefore, exploring a safe and accurate diagnostic method to identify vulnerable plaques will contribute to decreasing cardio-cerebrovascular events [17]. A previous study showed that CEUS could identify vulnerable plaques by evaluating IPN (and plaque ulceration) [18]. The leukocytes in circulation can colonize plaques and then induce an inflammatory response that stimulates the formation of neovascularizations in atherosclerotic plaques [19]. The present study evaluated IPN in obvious plaques using CEUS and analyzed the correlations between CEUS quantitative parameters and differential leucocyte counts. The present study also revisited the diagnostic value of CEUS in identifying vulnerable atherosclerotic plaques.

The quantitative parameters of CEUS (PTIC, MTIC, PFC, SFC, and AUCFC) reflect the microvessel density of vulnerable atherosclerotic plaques and their blood perfusion and perfusion patterns from different sides. This study showed that the mean values of PTIC, MTIC, PFC, SFC, and AUCFC in the ACI group were significantly higher than those in the asymptomatic group. This indicated that the carotid atherosclerotic plaques of patients with cerebral infarction had more neovascularization and vulnerability. Moguillansky et al. [20] established an artery atherosclerotic plaque model. They performed atherosclerotic plaque CEUS and compared it with pathological results. They found that the quantitative parameters of CEUS were closely related to the microvessel density of the plaque and suggested that CEUS could evaluate its pathological features and stability. The IPN, the second- or third-order branches of the vasa vasorum, primarily come from the adventitial vasa vasorum, which twists through medial smooth muscle to the intima [21]. Thus, the partial oxygen pressure in the IPN is the lowest. Previous research has shown that increased intima-media thickness and the formation of atherosclerotic plaques could further decrease the partial oxygen pressure of the terminal vasa vasorum and form a hypoxic-ischemic micro-environment, which stimulates neovascularization under the intima or within plaques [22]. These neovascularizations, which are immature and lack smooth muscle cells and a complete basement membrane in the wall with a larger interstitial space between endothelial cells, are thus prone to rupture and hemorrhage, resulting in cardio-cerebrovascular events [23]. Research by Hosseini et al. [24] of 179 symptomatic patients with carotid artery stenosis of more than 50% reported that the incidence of IPN and hemorrhage was 63.7% and the recurrence of ipsilateral cerebral ischemic events was up to 92%. A similar study showed that intraplaque hemorrhage occurred in 57% of specimens from symptomatic patients with internal carotid artery stenosis who had undergone an internal carotid endarterectomy. The study also found that IPN grades classified by CEUS have a direct correlation with neo-angiogenesis density in the specimen and are closely related to intraplaque hemorrhage and the percentage of macrophages [25]. This indicates that carotid artery CEUS could estimate intraplaque hemorrhage and reflect inflammatory activities in the plaque by measuring neoangiogenesis [26].

Atherosclerosis, vascular inflammation, and neovascularization are closely related [27]. There are two hypotheses for atherosclerotic vascular inflammation and intraplaque inflammatory activities. According to the traditional concept, vascular inflammation is considered to be an “inside-out” response focused on monocyte adhesion and lipid oxidation hypotheses [28]. However, increasing evidence supports an “outside-in” hypothesis, in which intraplaque inflammation is initiated in the arterial adventitia and progresses inward toward the intima [29]. The intraplaque inflammatory activities and neovascularization all stem from a continuous vascular inflammatory reaction. This hypothesis reminds us that an inflammatory state of circulating blood may spread into atherosclerotic plaques through abundant and immature neo-angiogenesis [30]. This study found that the perivascular total leukocyte and neutrophil counts of patients with ACI were significantly higher but that the lymphocyte count was significantly lower. An increased neutrophil count is positively correlated with MTIC, which reflects the IPN. A decreased lymphocyte count is negatively correlated with MTIC and AUCFC, reflecting intraplaque blood perfusion. Asuman et al. [31] demonstrated that the neutrophil to lymphocyte ratio (N/L ratio) was highest in patients with ACI compared with transient cerebral ischemia and control subjects. Inflammation plays a fundamental role in the development and progression of atherosclerosis, and leukocytes participate in the plaque formation and destabilization, thereby inducing acute thrombotic events. Therefore, the variation in the perivascular leucocyte could be a novel noninvasive marker for cerebrovascular events [32]. Besides, a clinical study demonstrated that with intraplaque hypermetabolism, high-oxygen consumption macrophages more easily produce a hypoxic microenvironment compared with increased intima-media thickness [33]. Oxygen diffusive disorder in thickened intima-media and increased oxygen consumption of inflammatory cells both lead to a hypoxic microenvironment state and stimulate neovascularization, intraplaque hemorrhage, and the rupture of atherosclerotic plaques [7]. A recent study showed that the adventitia not only provides structural support for the vessel walls but also facilitates atherosclerosis, as well as the formation of neo-intima and vulnerable plaques by “outside-in” inflammatory cells and the transfer of fibroblasts [34]. Though prospective observational data is still lacking, more advanced modalities have been introduced, including intravascular ultrasound (IVUS), virtual-histology IVUS, optical coherence tomography (OCT), et al. They can better delineate microstructures of plaques, and may potentially lead to a major shift in the management of millions of patients with ACI.

This study has some limitations. First, the number of patients enrolled was relatively small, and we did not compare the differences between the plaque ulcer group and the plaque integrity group. Second, accuracy may have been affected by evaluating intraplaque inflammatory activities through the peri-vascular leukocyte count because it is not equivalent to the inflammatory cell count in the plaques.

Conclusions

In conclusion, carotid artery CEUS could be used to assess plaque vulnerability by quantitatively analyzing IPN. Carotid artery CEUS could also serve as a visualization diagnostic tool for the adventitia vasa vasorum. This may provide a new perspective on the “outside-in” theory of inflammatory activities in atherosclerotic plaques.

Abbreviations

ACI:

Acute Cerebral Infarction

AUCFC :

Area Under the Curve

CA:

Calcified Area

CEUS:

Contrast-enhanced Ultrasound

FC:

Fitting the Gamma Curve

IPN:

Intraplaque Neovascularization

MTIC :

Mean Time-signal Intensity

OPA:

Obvious Plaque Area

PFC :

Maximum Peak Value

PTIC :

Peak Time-signal Intensity

ROC:

Receiver Operating Characteristic Curve

SFC :

Sharpness of FC

TIC:

Time-signal Intensity; Curve

References

  1. 1.

    Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754–832.

  2. 2.

    Gupta A, Baradaran H, Al-Dasuqi K, Knight-Greenfield A, Giambrone AE, Delgado D, et al. Gadolinium enhancement in intracranial atherosclerotic plaque and ischemic stroke: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5:e003816.

  3. 3.

    Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J. 2011;32:1977–85.

  4. 4.

    Janssen H, Wagner CS, Demmer P, Callies S, Sölter G, Loghmani-khouzani H, et al. Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition. Dis Model Mech. 2015;8:1071–80.

  5. 5.

    Scheiermann C, Frenette PS, Hidalgo A. Regulation of leucocyte homeostasis in the circulation. Cardiovasc Res. 2015;107:340–51.

  6. 6.

    Huang R, Abdelmoneim SS, Ball CA, Nhola LF, Farrell AM, Feinstein S, et al. Detection of carotid atherosclerotic plaque neovascularization using contrast enhanced ultrasound: a systematic review and meta-analysis of diagnostic accuracy studies. J Am Soc Echocardiogr. 2016;29:491–502.

  7. 7.

    Schmidt C, Fischer T, Rückert RI, Oberwahrenbrock T, Harms L, Kronenberg G, et al. Identification of neovascularization by contrast–enhanced ultrasound to detect unstable carotid stenosis. PLoS One. 2017;12:e0175331.

  8. 8.

    Legein B, Temmerman L, Biessen EA, Lutgens E. Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci. 2013;20:3847–69.

  9. 9.

    Liesz A, Hu X, Kleinschnitz C, Offner H. The functional role of regulatory lymphocytes in stroke: facts and controversies. Stroke. 2015;46:1422–30.

  10. 10.

    World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva: WHO Department of Non communicable Disease Surveillance; 1999.

  11. 11.

    Li Z, Du L, Wang F, Luo X. Assessment of the arterial stiffness in patients with acute ischemic stroke using longitudinal elasticity modulus measurements obtained with shear wave Elastography. Med Ultrason. 2016;18:182–9.

  12. 12.

    Li ZJ, Liu Y, Du LF, Luo XH. Evaluating arterial stiffness in type 2 diabetes patients using ultrasonic radiofrequency. J Huazhong Univ Sci Technolog Med Sci. 2016;36:442–8.

  13. 13.

    Kim SA, Park SH, Jo SH, Park KH, Kim HS, Han SJ, et al. Alterations of carotid arterial mechanics preceding the wall thickening in patients with hypertension. Atherosclerosis. 2016;248:84–90.

  14. 14.

    Nandalur KR, Hardie AD, Raghavan P, Schipper MJ, Baskurt E, Kramer CM. Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume. Stroke. 2007;38:935–40.

  15. 15.

    Alsulaimani S, Gardener H, Elkind MS, Cheung K, Sacco RL, Rundek T. Elevated homocysteine and carotid plaque area and densitometry in the northern Manhattan study. Stroke. 2013;44:457–61.

  16. 16.

    Howard DP, van Lammeren GW, Rothwell PM, Redgrave JN, Moll FL, de Vries JP, et al. Symptomatic carotid atherosclerotic disease: correlations between plaque composition and ipsilateral stroke risk. Stroke. 2015;46:182–9.

  17. 17.

    Stefanadis C, Antoniou CK, Tsiachris D, Pietri P. Coronary atherosclerotic vulnerable plaque: current perspectives. J Am Heart Assoc. 2017;6:e005543.

  18. 18.

    Steinl DC, Kaufmann BA. Ultrasound imaging for risk assessment in atherosclerosis. Int J Mol Sci. 2015;16:9749–969.

  19. 19.

    Rafailidis V, Pitoulias G, Kouskouras K, Rafailidis D. Contrast-enhanced ultrasonography of the carotids. Ultrasonography. 2015;34:312–23.

  20. 20.

    Moguillansky D, Leng X, Carson A, Lavery L, Schwartz A, Chen X, et al. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur Heart J. 2011;32:646–53.

  21. 21.

    Osborn EA, Jaffer FA. Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets. Curr Opin Cardiol. 2015;30:671–80.

  22. 22.

    Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol. 2008;51:1258–65.

  23. 23.

    Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab. 2016;36:172–86.

  24. 24.

    Hosseini AA, Kandiyil N, Macsweeney ST, Altaf N, Auer DP. Carotid plaque hemorrhage on magnetic resonance imaging strongly predicts recurrent ischemia and stroke. Ann Neurol. 2013;73:774–84.

  25. 25.

    Teng Z, Sadat U, Brown AJ, Gillard JH. Plaque hemorrhage in carotid artery disease: pathogenesis, clinical and biomechanical considerations. J Biomech. 2014;47:847–58.

  26. 26.

    You X, Huang P, Zhang C, Wang M, Zhang Y, Hong Y, et al. Relationship between enhanced intensity of contrast enhanced ultrasound and microvessel density of aortic atherosclerostic plaque in rabbit model. PLoS One. 2014;9:e92445.

  27. 27.

    Li J, Flammer AJ, Reriani MK, Matsuo Y, Gulati R, Friedman PA, et al. High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk. Circ J. 2013:780–5.

  28. 28.

    Langheinrich AC, Kampschulte M, Scheiter F, Dierkes C, Stieger P, Bohle RM, et al. Atherosclerosis, inflammation and lipoprotein glomerulopathy in kidneys of apoE−/−/LDL−/− double knockout mice. BMC Nephrol. 2010;11:18.

  29. 29.

    Li G, Chen SJ, Oparil S, Chen YF, Thompson JA. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation. 2000;101:1362–5.

  30. 30.

    Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25:2054–61.

  31. 31.

    Celikbilek A, Ismailogullari S, Zararsiz G. Neutrophil to lymphocyte ratio predicts poor prognosis in ischemic cerebrovascular disease. J Clin Lab Anal. 2014;28:27–31.

  32. 32.

    Xu J, Lu X, Shi GP. Vasa Vasorum in atherosclerosis and clinical significance. Int J Mol Sci. 2015;16:11574–608.

  33. 33.

    Mikhed Y, Daiber A, Steven S. Mitochondrial oxidative stress, mitochondrial DNA damage and their role in age-related vascular dysfunction. Int J Mol Sci. 2015;16:15918–53.

  34. 34.

    Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res. 2007;75:640–8.

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by the Shanghai Health and Family Planning Commission Fund (201640043); Shanghai Science and Technology Committee Fund (grant number 16411969300); Interdisciplinary Program of Shanghai Jiao Tong University (project number YG2015MS28); Three-year Plan for Clinical Skills and Innovation in Municipal Hospitals (project number 16CR3105B); Technology Transfer Project of Science & Technology Dept., Shanghai Jiao Tong University School of Medicine (grant number ZT201710 and ZT201711); and Shanghai Songjiang District Science and Technology Project (18sjkjgg72 and 18sjkjgg53).

Author information

ZJ L designed this study. XH L, WB L, Y B and ZJ L conducted the study and collected important background data. XH L, ZJ L, R W and LF D drafted the manuscript. All authors have read and approved the manuscript.

Correspondence to Zhaojun Li.

Ethics declarations

Ethics approval and consent to participate

Clinical investigations were performed according to the Declaration of Helsinki. The study protocol was approved by the ethics committee of Shanghai General Hospital (2017KY009) and registered with the official website of China Clinical Trial Registration Center (ChiCTR1800016590). The inform consents were signed by all subjects.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Keywords

  • Ultrasonography
  • Cerebral infarction
  • Carotid artery
  • Atherosclerosis
  • Leukocyte